China PEACE Million Persons Project
1 other identifier
observational
4,000,000
1 country
1
Brief Summary
China PEACE Millions Persons Project is a national screening project for cardiovascular disease in China. This Project was approved by National Health and Family Planning Commission (NHFPC), China and founded by Ministry of Finance, China in 2014. The specific objectives of the project are to:
- 1.identify subjects at high-risk of CVD and provide counseling for medication and lifestyle improvements
- 2.evaluate the feasibility of such screening methods for subjects at high risk of CVD, and to assess the effect of health counseling on CVD incidence rates and risk factors control
- 3.inform future intervention and long-term follow up efforts for primary and secondary CVD prevention in China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 24, 2015
CompletedFirst Posted
Study publicly available on registry
August 31, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedAugust 17, 2020
August 1, 2020
7 years
August 24, 2015
August 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Cardiovascular diseases
Number of new cardiovascular diseases in high-risk subjects
5 years
Eligibility Criteria
Residents from the communities or villages in selected sites
You may qualify if:
- years old
- registered in the Hukou of the selected region
- sign the consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fuwai hospital
Beijing, Beijing Municipality, China
Related Publications (5)
Liu X, Lin S, Zhang H, Zhang X, Wu C, Chen B, Yang Y, Cui J, Xu W, Song L, Yang H, He W, Zhang Y, Li X, Lu J. Association of HDL subclass components with all-cause and cardiovascular mortality: a prospective cohort study based on the ChinaHEART project. Lipids Health Dis. 2026 Jan 27. doi: 10.1186/s12944-026-02874-w. Online ahead of print.
PMID: 41593465DERIVEDWang Y, Peng K, Xu W, Huang X, Liu X, Li Y, Lu J, Yang Y, Chen B, Shi Y, Han G, Zhang X, Cui J, Song L, Tian A, Runsi W, Wang C, Tian Y, Wu Y, Lin C, Peng W, Li X, Hu S. Cardiovascular disease-specific and all-cause mortality across socioeconomic status and lifestyles among patients with established cardiovascular disease in communities of China: data from a national population-based cohort. Heart. 2025 Oct 29;111(22):1092-1100. doi: 10.1136/heartjnl-2024-324766.
PMID: 40081938DERIVEDWang R, Wang Y, Lu J, Li Y, Wu C, Yang Y, Cui J, Xu W, Song L, Yang H, He W, Zhang Y, Zhang X, Li X, Hu S. Forecasting cardiovascular disease risk and burden in China from 2020 to 2030: a simulation study based on a nationwide cohort. Heart. 2025 Feb 12;111(5):205-211. doi: 10.1136/heartjnl-2024-324650.
PMID: 39638429DERIVEDChina PEACE Collaborative Group; Zhou T, Wang Y, Zhang H, Wu C, Tian N, Cui J, Bai X, Yang Y, Zhang X, Lu Y, Spatz ES, Ross JS, Krumholz HM, Lu J, Li X, Hu S. Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional study. Lancet Glob Health. 2023 Jan;11(1):e83-e94. doi: 10.1016/S2214-109X(22)00428-4.
PMID: 36521957DERIVEDLu J, Xuan S, Downing NS, Wu C, Li L, Krumholz HM, Jiang L. Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project pilot. BMJ Open. 2016 Jan 4;6(1):e010200. doi: 10.1136/bmjopen-2015-010200.
PMID: 26729395DERIVED
Biospecimen
For each high-risk subject, a 6mL whole blood sample is collected in an EDTA vacuum tube.A 10mL urine sample is also collected.
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Lixin Jiang, MD, PhD
China National Center for Cardiovascular Diseases
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2015
First Posted
August 31, 2015
Study Start
July 1, 2014
Primary Completion
July 1, 2021
Study Completion
July 1, 2021
Last Updated
August 17, 2020
Record last verified: 2020-08